Your Article Summary
USPTO issues a Notice of Allowance for MMDI's BetaWire Guidewire Patent
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/20/08
Minnesota Medical Development, Inc. (MMDI) announced that the United States Patent and Trademark Office has issued a Notice of Allowance for the company’s BetaWire guidewire technology. The BetaWire is a super-torque interventional guidewire manufactured from a Beta Titanium alloy.
| Previous Article | Next Article |
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
Takeda Pharmaceuticals North America, 07/02/09
Insulin detemir alert issued by FDA
American Pharmacists Association, 06/15/09
Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09
Article Search
Sponsor


See Latest Articles


